SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001558370-24-005767
Filing Date
2024-04-25
Accepted
2024-04-25 16:10:20
Documents
15
Period of Report
2024-04-25
Items
Item 2.02: Results of Operations and Financial Condition
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K tmb-20240425x8k.htm   iXBRL 8-K 46928
2 EX-99.1 tmb-20240425xex99d1.htm EX-99.1 178053
  Complete submission text file 0001558370-24-005767.txt   390300

Data Files

Seq Description Document Type Size
3 EX-101.SCH tmb-20240425.xsd EX-101.SCH 3880
4 EX-101.DEF tmb-20240425_def.xml EX-101.DEF 13165
5 EX-101.LAB tmb-20240425_lab.xml EX-101.LAB 18683
6 EX-101.PRE tmb-20240425_pre.xml EX-101.PRE 12739
18 EXTRACTED XBRL INSTANCE DOCUMENT tmb-20240425x8k_htm.xml XML 6295
Mailing Address 500 WARREN CORPORATE CENTER DRIVE WARREN NJ 07059
Business Address 500 WARREN CORPORATE CENTER DRIVE WARREN NJ 07059 9082227000
PTC THERAPEUTICS, INC. (Filer) CIK: 0001070081 (see all company filings)

IRS No.: 043416587 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35969 | Film No.: 24876370
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)